Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine response to pain in Alzheimer's disease.We plan to study the effect of diffuse noxious inhibitory controls(counterirritation phenomenon)and the autonomic nerv...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Rambam Health Care Campus
NCT06597942 · Alzheimer&Amp;Amp;#39;s Disease, Alzheimer Disease, and more
NCT07037550 · Dementia, Mild Cognitive Impairment, and more
NCT06718686 · Dementia Alzheimer Type, Dementia Associated With Cerebrovascular Disease
NCT07533084 · Active Aging Individuals Aged 65 and Over, Aging, and more
NCT07237958 · Alzheimer Disease (AD), Dementia Alzheimer Type, and more
Neurocognitive unit,Neurophysiology laborator Rambam Health Care Campus
Haifa
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions